Dishman Pharmaceuticals and Chemicals Limited
Report Date | Research house | Description | Reco | At Price | Target Price | UpSide /DownSide | Download |
24-May-17
|
Nirmal Bang Sec
|
PAT: For the quarter, it stood at Rs428mn which was 32.9%/23.7% b..
|
Buy
|
305
|
387
|
26.9
|
|
18-May-17
|
B P Equities
|
Operationally strong quarter; Maintain buy
Dishman Pharma Q4FY1..
|
BUY
|
303
|
340
|
12.21
|
|
18-May-17
|
Nirmal Bang Sec
|
Business Growth On Strong Footing – Revaluation On EV/EBITDA Basi..
|
Buy
|
305
|
387
|
26.9
|
|
3-May-17
|
Nirmal Bang Sec
|
Growth in CRAMS business: Over the past several years, DPCL has c..
|
BUY
|
311
|
380
|
22.2
|
|
2-May-17
|
Nirmal Bang Sec
|
-
|
BUY
|
311
|
380
|
22.2
|
|
asdsa
Upcoming Events and Recent Updates
No Recent Updates.